A series of N(7) -azacyclohexyl-4-oxo-4,7-dihydrothieno[2,3-b]-pyridine-5-carboxylic acids 9a -c, related congeners 9d -g and their methyl esters 8a -g were prepared by cyclization of the respective 2-[(2,5-dichlorothien-3-yl)carbonyl]-3-[(N(7)-azacyclyl/acyclic)amino]acrylates 7a -g. The latter intermediates are accessible from methyl 2-[(2,5-dichlorothien-3-yl)carbonyl]-3-ethoxyacrylate (6). Of the present series, the 7-(N,N-dimethylamino) derivative 9d exhibited good activity, especially against Klebsiella pneumoniae and Salmonella paratyphi A (MIC = 0.5 and 1.0 µg mL −1 , respectively).
Introduction
Several 4-oxothieno [2,3-b] pyridine-5-carboxylic acids, potential bioisosteres of quinolone antibacterials, e. g. norfloxacin (1a) [3] , ciprofloxacin (1b) [4] and ofloxacin (2) [5] (Fig. 1) , were prepared and biotested [2, 6 -13] . Substitution at the N(7)-position of thienopyridones has been reported for alkyl groups, e. g. compounds 3a [6] and 3b [7, 8] (Fig. 1) which exhibited a good level of activity against Gramnegative bacteria. N(7)-Aryl substitution has also been achieved, exemplified by compounds 4a, b [2] , which exhibited a good level of activity against Gramnegative and Gram-positive bacterial strains. Quite recently, N(7)-heteroaryl substitution, exemplified by compound 4c [1] , has also been investigated.
However, incorporation of saturated N(7)-azaheterocyclyl substituents has not been described in the literature for the thieno [2,3-b] pyridine class. Accordingly, and as a continuation of our research project directed toward structure-activity relationship (SAR) studies, we report in the present work on the synthe-0932-0776 / 09 / 1100-1625 $ 06.00 c 2009 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com sis and the antibacterial activity of a new series of 2-chloro-4-oxothieno [2,3-b] pyridine-5-carboxylic esters 8a -c and acids 9a -c having selected azacyclohexyl appendages and related congeners at the N(7) locus (Scheme 1). Herein, the choice is confined to piperazino, morpholino, piperidino, N,N-dimethylamino, chiral alaninol and related biophoric amino entities.
Results and Discussion

Chemistry
The preparation of the new thieno [2,3-b] pyridines 9a -g is achieved by utilizing 3-(2,5-dichlorothien-3-yl)-3-oxopropanoate (5) as starting material (accessible from 3-acetyl-2,5-dichlorothiophene) [14] , and constructing the pyridone nucleus thereupon through a series of conversions, as illustrated in Scheme 1. Thus, treatment of the β -keto ester 5 with triethyl orthoformate in acetic anhydride gave the corresponding methyl 3-ethoxyacrylate derivative 6 [7] which serves as the common intermediate for the synthe- sis of the target compounds 9a -g. Herein, condensation of the enol ether 6 with the appropriate amino compound resulted in smooth production of the respective 3-substituted aminoacrylates 7a -g. Cyclization of deprotonated 7a -g (using NaH in tetrahydrofuran) yielded the respective methyl 4-oxothieno [2,3-b] pyridine-5-carboxylates 8a -g. This intramolecular nucleophilic heteroaromatic substitution (S N -Ar) reaction is presumably facilitated by the presence of the vicinal electron-withdrawing keto group at C-3 and neighboring chlorine atom at C-5 . Saponification of esters 8a -g furnished the desired N-(7)-substituted-4-oxothieno [2,3-b] pyridine-5-carboxylic acids 9a -g.
The new compounds 7 -9 were characterized by elemental analyses, MS and NMR spectral data. These data, detailed in the Experimental Section, are consistent with the suggested structures. Thus, their MS spectra displayed the correct molecular ions [M] + for which the m/z values are in agreement with those calculated from the respective molecular formulas.
1 H and 13 C signal assignments to the different protons and carbons in the NMR spectra of the new compounds followed from DEPT and 2D (COSY, HMQC, HMBC) experiments which showed correlations that helped in the full assignments. Each of the 1 H signals, belonging to the different hydrogens in the acyclic enamino-keto esters 7a -g, is displayed as two sets of resonances with unequal peak areas; this feature is in accordance with the existence of Z/E diastereomeric forms in solution. Likewise, 13 C-signal doubling, arising from Z/E diastereomers, is also observed for a number of carbons such as C-4, C-5, C-4 , C-2 , C-3 and ester-CH 3 . Such a phenomenon is well-known and has been previously documented for related systems [2, 7] .
Antibacterial activity
Compounds 9a -g were tested in vitro as sodium salts in aqueous solution against eight different bacterial species (listed in Table 1 ) using ofloxacin (2, OFL) as reference. The antibacterial activity was evaluated by the minimal inhibitory concentration (MIC) technique.
Compound 9d exhibits a moderate to low level of antibacterial activity against the test organisms except for St. Faecalis and P. aeruginosa where it is inactive at ≥ 128 µg mL −1 . Compounds 9b -g did not show any significant antibacterial activity.
In conclusion, the 7-(N,N-dimethylamino) derivative 9d might be envisaged as a lead compound for further manipulations. In particular, fluorination of va- cant CH-thiophene sites in 9d might produce drugable fluorothieno [2,3-b] pyridones comparable in potency to marketed fluoroquinolone antibacterials.
Experimental Section
3-Acetyl-2,5-dichlorothiophene was purchased from Fluorochem (England), (R)-alaninol, (S)-alaninol, 1-amino-4-methylpiperazine and N-aminomorpholine were purchased from Acros. 1-Aminopiperidine was a product from Aldrich. Sodium hydride (80 % dispersion in mineral oil) was obtained from Fluka. Tetrahydrofuran (THF) and dimethyl carbonate were dried before use. Melting points were determined on an electrothermal melting temperature apparatus. 1 H and 13 C NMR spectra were measured on a Bruker DPX-300 instrument. Chemical shifts are expressed in ppm with reference to TMS as internal standard. Mass spectra were obtained using a Finnigan MAT 731 spectrometer at 70 eV. Elemental analyses were preformed at M. H. W Laboratories, Arizona, USA.
Antibacterial tests
The MICs were determined by the conventional agar dilution procedures according to the method of Mueller-Hinton at pH = 7.4. Aqueous stock solutions (1000 µg mL −1 ) of the test compounds were prepared with 0.1 N NaOH. Serial dilutions were then made to obtain test concentrations in the range 128 -0.06 µg mL −1 . The agar plates were inoculated with approximately 10 5 CFU per spot. The agar plates were then incubated at 37 • C for 18 h. The MICs were taken as the lowest concentration of the test compounds that inhibits visible growth.
Synthesis of compounds 5 and 6
Methyl 3-(2,5-dichlorothien-3-yl)-3-oxopropanoate (5)
This compound was prepared from 3-acetyl-2,5-dichlorothiophene and dimethyl carbonate, following a recently reported procedure [7, 14] .
Methyl 2-[(2,5-dichlorothien-3-yl)carbonyl]-3-ethoxyacrylate (6)
A stirred mixture of compound 5 (5.3 g, 21 mmol), triethyl orthoformate (4.6 g, 32 mmol) and acetic anhydride (9.2 g, 90 mmol) was heated at 135 -140 • C for 3 -4 h. The resulting solution was concentrated in vacuo to give 6 as a brown viscous oil in nearly quantitative yield (∼ 6.4 g), which was used as such in the next step without further purification [7, 14] .
Preparation of methyl 2-[(2,5-dichlorothien-3-yl)carbonyl]-3-(N-substituted amino)acrylates 7a -g
General procedure
To a stirred solution of methyl 2-[(2,5-dichlorothien-3-yl)carbonyl]-3-ethoxyacrylate (6) (6.16 g, 20 mmol) in dichloromethane (50 mL) was added the particular amino compound (22 mmol) at 2 -4 • C. The resulting reaction was then stirred at 20 • C for 24 h. In the case of compound 7a, the particular amine (1-amino-4-methylpiperazine) was added at r. t., and the resulting reaction mixture was stirred at 40 -45 • C for 24 h. The solvent was then evaporated and the residue recrystallized from the appropriate solvent. Yields were in the range 60 -91 %.
Methyl 2-[(2,5-dichlorothien-3-yl)carbonyl]-3-[(4-methylpiperazin-1-yl)amino]acrylate (7a)
The compound was obtained as an off-white solid that was recrystallized from chloroform / petroleum ether (b. p. 40 -60 • C). Yield: 4.9 g (65 %), m. p. 99 -100 • C. - 1 (2d, 1H, J = 11.6, 11.6 Hz, 3-H, Z/E), 11.08, 9.67 (2d, 1H, J = 11.6, 11.6 Hz, NH, Z/E). 
Methyl 2-[(2,5-dichlorothien-3-yl)carbonyl]-3-[(morpholin-4-yl)amino]acrylate (7b)
The solid product was recrystallized from methanol. Yield: 5.9 g (81 %), m. p. 118 -119 • C. -1 H NMR 
Methyl 2-[(2,5-dichlorothien-3-yl)carbonyl]-3-N-(2,2-dimethylhydrazino)acrylate (7d)
The solid product was recrystallized from chloroform/diethyl ether. Yield: 3. 
Methyl (R)-2-[(2,5-dichlorothien-3-yl)carbonyl]-3-N-(2-hydroxy-1-methylethylamino)acrylate (7e)
The compound was obtained as an oil. Yield: 5.8 g (86 %). 
Methyl (S)-2-[(2,5-dichlorothien-3-yl)carbonyl]-3-N-(2-hydroxy-1-methylethyl)acrylate (7f)
This compound was obtained as an oil. Yield: 5.7 g (84 %). -C 12 H 13 NO 4 SCl 2 (338.21): calcd. C 42.62, H 3.87, N 4.14; found C 42.45, H 3.82, N 4.11. The spectral data for this compound are in complete match with those of its (R)-enantiomer.
Methyl (R)-2-[(2,5-dichlorothien-3-yl)carbonyl]-3-N-(2-phenylethylamino)acrylate (7g)
The compound was recrystallized from benzene/ petroleum ether. Yield: 6. 
Preparation of methyl 7-(N-substituted amino)-and 7-alkyl-2-chloro-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylates 8a -g
General procedure
To a stirred solution of the particular methyl 3-(Nsubstituted amino)-or methyl 3-(N-alkylamino)-2-[(2,5-dichlorothien-3-yl)carbonyl]acrylate 7a -g (16 mmol) in dry THF (70 mL) was added sodium hydride (80 % dispersion in mineral oil; 0.5 g, 20 mmol). The reaction mixture was then stirred at r. t. for 30 min. The temperature was allowed to rise to 60 -62 • C and maintained at that temperature for 2 -3 h. The solvent was then evaporated, and the residue was washed with water. The solid product was purified by crystallization from the appropriate solvent.
Methyl 2-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylate (8a)
The obtained solid was recrystallized from chloroform/methanol. Yield: 4.5 g (82 %), m. p. 210 -211 • C. 
Methyl 2-chloro-7-(morpholin-4-yl)-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylate (8b)
The solid obtained was recrystallized from chloroform/petroleum ether. Yield: 4. 
Methyl 2-chloro-4-oxo-7-(piperidin-1-yl)-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylate (8c)
The obtained solid was recrystallized from a mixture of chloroform/diethyl ether. Yield: 4.6 g (88 %), m. p. 160 -162 • C. 
Methyl 2-chloro-7-(dimethylamino)-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylate (8d)
The obtained solid was recrystallized from methanol. Yield: 1. 
Methyl (R)-2-chloro-7-[N-(2-hydroxy-1-methylethyl)]-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylate (8e)
The obtained solid was recrystallized from chloroform/diethyl ether. Yield 
Methyl (S)-2-chloro-7-[N-(2-hydroxy-1-methylethyl)]-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylate (8f)
The obtained solid was recrystallized from chloroform/diethyl ether. Yield: 2. 
Methyl (R)-2-chloro-7-[N-(2-phenylethyl)]-4-oxo-4,7-dihydrothieno[2,3-b]-pyridine-5-carboxylate (8g)
The obtained solid was purified by recrystallization from chloroform/diethyl ether. Yield: 4.7 g (85 %), m. p. 178 -180 • C. The appropriate methyl 7-(N-substituted amino)-or methyl 7-alkyl-2-chloro-4-oxo-4,7-dihydro[2,3-b]pyridine-5-carboxylate 8a -g (5.0 mmol) was added to an ethanolic solution of sodium hydroxide (40 mL, 2 M). The resulting solution was stirred for 1 -2 h, filtered, diluted with H 2 O (40 mL) and then acidified with 8 % aqueous hydrochloric acid. The precipitated product was collected by suction filtration, washed with water, dried and recrystallized from the appropriate solvent.
2-Chloro-7-(4-methylpiperazin-1-yl)-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylic acid (9a)
The solid product was recrystallized from chloroform/diethyl ether. Yield: 1.36 g (83 %), m. p. 235 -236 • C. 
2-Chloro-7-(morpholin-4-yl)-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxylic acid (9b)
The solid compound was obtained by recrystallization from chloroform/petroleum ether. Yield: 1.37 g (87 %), m. p. 245 -246 • C (dec.). 
